Page last updated: 2024-08-23

daunorubicin and 5,11-dimethyl-5h-indolo(2,3-b)quinoline

daunorubicin has been researched along with 5,11-dimethyl-5h-indolo(2,3-b)quinoline in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Godlewska, J; Kaczmarek, L; Luniewski, W; Peczynska-Czoch, W; Piskozub, M; Switalska, M; Wietrzyk, J1

Other Studies

1 other study(ies) available for daunorubicin and 5,11-dimethyl-5h-indolo(2,3-b)quinoline

ArticleYear
New derivatives of 11-methyl-6-[2-(dimethylamino)ethyl]-6H-indolo[2,3-b]quinoline as cytotoxic DNA topoisomerase II inhibitors.
    Bioorganic & medicinal chemistry letters, 2012, Oct-01, Volume: 22, Issue:19

    Topics: Animals; Antineoplastic Agents; BALB 3T3 Cells; Cell Cycle; Cell Line, Tumor; Cell Proliferation; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Fibroblasts; HL-60 Cells; Humans; Indoles; Jurkat Cells; Male; MCF-7 Cells; Mice; Molecular Structure; Quinolines; Structure-Activity Relationship; Topoisomerase II Inhibitors

2012